At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,237 enrolled
Drug / intervention
Vonoprazandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Special Drug Use Surveillance of Takecab Tablets for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
In Brief
An observational study evaluating Vonoprazan for Reflux Esophagitis. Completed, enrolled 1,237 participants across 1 site.
Detailed Summary
The purpose of this survey is to evaluate the safety and effectiveness of long-term administration of vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine clinical settings.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsReflux Esophagitis
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMar 2016
First PostedJul 2017
Primary CompletionAug 2018
TodayJul 2026
First PostedJul 11, 2017
Enrollment StartMar 1, 2016
Primary CompletionAug 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 9.0 years ago
Interventions
Vonoprazandrug
Vonoprazan tablets